UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.6% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
8176
Sagtec Global
SAGT
$23.7M
| $16.2K | ﹤0.01% |
12,985
+3,776
| +41% | +$5.32K |
2025 Q4
2 quarters
|
|
8177
DELISTED
iShares US Consumer Focused ETF
IEDI
| $16.2K | ﹤0.01% |
+296
| New | +$16.4K |
2026 Q2
0 quarters
|
|
8178
Electra Battery Materials
ELBM
$47.5M
| $16.2K | ﹤0.01% |
26,840
+5,272
| +24% | +$3.23K |
2025 Q3
3 quarters
|
|
8179
Drugs Made In America Acquisition Corp Units
DMAAU
| $16.2K | ﹤0.01% |
1,525
+4
| +0.3% | +$43 |
2025 Q1
5 quarters
|
|
8180
Crown Reserve Acquisition Corp I
CRAC
$230M
| $16.2K | ﹤0.01% |
+1,600
| New | +$16.1K |
2026 Q2
0 quarters
|
|
8181
Cyngn
CYN
$4.39M
| $16.2K | ﹤0.01% |
11,624
-5,724
| -33% | -$8.48K |
2025 Q1
5 quarters
|
|
8182
DELISTED
Perfect Corp
PERF
| $16.1K | ﹤0.01% |
9,725
+9,625
| +9,625% | +$16.2K |
2025 Q4
2 quarters
|
|
8183
State Street SPDR S&P Kensho Final Frontiers ETF
ROKT
$148M
| $16.1K | ﹤0.01% |
+135
| New | +$15.7K |
2026 Q2
0 quarters
|
|
8184
Sterling Capital Short Duration Bond ETF
SCSB
$32.8M
| $16.1K | ﹤0.01% |
+645
| New | +$16.1K |
2026 Q2
0 quarters
|
|
8185
Franklin FTSE Asia ex Japan ETF
FLAX
$66.7M
| $16.1K | ﹤0.01% |
+431
| New | +$15.3K |
2026 Q2
0 quarters
|
|
8186
Where Food Comes From
WFCF
$78.1M
| $16K | ﹤0.01% |
1,233
+1,042
| +546% | +$12.8K |
2023 Q4
10 quarters
|
|
8187
DELISTED
Nvni Group Limited Warrants
NVNIW
| $16K | ﹤0.01% |
553,083
+9,540
| +2% | +$406 |
2026 Q1
1 quarter
|
|
|
SVA
8188
DELISTED
Sinovac Biotech, Ltd
SVA
| $16K | ﹤0.01% |
2,479
+250
| +11% | +$1.62K |
2025 Q2
4 quarters
|
|
8189
Healthcare Triangle
HCTI
$3.74M
| $16K | ﹤0.01% |
443
-1,593
| -78% | -$73.6K |
2021 Q4
18 quarters
|
|
8190
Madison Dividend Value ETF
DIVL
$63.9M
| $16K | ﹤0.01% |
657
+409
| +165% | +$10.1K |
2025 Q4
2 quarters
|
|
8191
Citius Pharmaceuticals
CTXR
$14.4M
| $15.9K | ﹤0.01% |
26,335
-28,690
| -52% | -$19.4K |
2023 Q1
13 quarters
|
|
|
COLA
8192
DELISTED
Columbus Acquisition Corp
COLA
| $15.9K | ﹤0.01% |
+1,496
| New | +$16K |
2026 Q2
0 quarters
|
|
8193
Senti Biosciences Holdings
SNTI
$6.11M
| $15.9K | ﹤0.01% |
14,432
+5,795
| +67% | +$5.67K |
2025 Q4
2 quarters
|
|
8194
TCW Senior Loan ETF
SLNZ
$226M
| $15.8K | ﹤0.01% |
347
-5
| -1% | -$228 |
2025 Q4
2 quarters
|
|
8195
Return Stacked U.S. Stocks & Gold/Bitcoin ETF
RSSX
$92.5M
| $15.8K | ﹤0.01% |
+689
| New | +$17.8K |
2026 Q2
0 quarters
|
|
8196
Beneficient
BENF
$10.5M
| $15.7K | ﹤0.01% |
4,271
-1,717
| -29% | -$5.97K |
2024 Q1
9 quarters
|
|
8197
Fifth Era Acquisition Corp I Units
FERAU
| $15.7K | ﹤0.01% |
1,472
-20
| -1% | -$213 |
2025 Q1
5 quarters
|
|
8198
First Trust Exchange-Traded Fund VI First Trust S&P International Dividend Aristocrats ETF
FID
$170M
| $15.7K | ﹤0.01% |
731
+598
| +450% | +$13.1K |
2026 Q1
1 quarter
|
|
8199
KALA BIO
KALA
$3.43M
| $15.7K | ﹤0.01% |
9,057
+7,720
| +577% | +$37.5K |
2023 Q3
11 quarters
|
|
8200
United-Guardian
UG
$40.7M
| $15.6K | ﹤0.01% |
2,187
+1,698
| +347% | +$11.8K |
2014 Q4
46 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,282 new, 4,216 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,282 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.